A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2016
At a glance
- Drugs Azacitidine (Primary) ; Cytarabine; Fludarabine
- Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia
- Focus Adverse reactions
- 30 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 31 Jan 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 28 May 2013 New trial record